Suresh's profile was created using:
Sort By:

1-6 of 6 online sources for Suresh Mahajan

  • View Online Source
    www.smartsilveronline.com/biosmahajan.shtml - [Cached Version]
    Published on: 5/1/2007    Last Visited: 5/1/2007  

    Suresh Mahajan, Ph.D.NanoHorizons
    ...
    Suresh Mahajan, PhD. of Pulsar Ventures

    Was Chief Medical Officer and Vice President of R&D of Catalytica, Inc., a successful biotechnology company that was sold in 2000 for $800 million; led development of catalytic technology platform for the pharmaceutical industry that was led to Catalytica's growth from start-up to $400 million in revenue in 5 years; over 30 years of experience in discovery and development of new technology in the pharmaceutical and chemical industries; PhD. in chemical engineering from Purdue University.

  • View Online Source
    www.smartsilveronline.com/management.shtml - [Cached Version]
    Published on: 5/1/2007    Last Visited: 5/1/2007  

    Suresh Mahajan, Ph.D. Director Former CTO and VP/R&D of Catalytica, Inc.

  • View Online Source
    NanoHorizons - [Cached Version]
    Published on: 1/18/2008    Last Visited: 1/18/2008  

    Suresh Mahajan, Ph.D. Director Former CTO and VP/R&D of Catalytica, Inc.

  • View Online Source
    NanoHorizons - [Cached Version]
    Published on: 12/14/2007    Last Visited: 12/14/2007  

    Suresh Mahajan, Ph.D.NanoHorizons
    ...
    Suresh Mahajan, PhD. of Pulsar Ventures

    Was Chief Medical Officer and Vice President of R&D of Catalytica, Inc., a successful biotechnology company that was sold in 2000 for $800 million; led development of catalytic technology platform for the pharmaceutical industry that was led to Catalytica's growth from start-up to $400 million in revenue in 5 years; over 30 years of experience in discovery and development of new technology in the pharmaceutical and chemical industries; PhD. in chemical engineering from Purdue University.

  • View Online Source
    NanoHorizons - [Cached Version]
    Published on: 1/18/2008    Last Visited: 1/18/2008  

    Joseph D. Cuiffi, Ph.D. | James Delattre, Ph.D. | Ned Satterfield | Stephen Fonash, Ph.D. | Robert F. Burlinson, M.B.A, C.P.A. | Edward Frymoyer, Ph.D. | Suresh Mahajan, Ph.D. | Peter M. Fonash, Ph.D.
    ...
    Suresh Mahajan, PhD.

    Was Chief Medical Officer and Vice President of R&D of Catalytica, Inc., a successful biotechnology company that was sold in 2000 for $800 million; led development of catalytic technology platform for the pharmaceutical industry that was led to Catalytica's growth from start-up to $400 million in revenue in 5 years; over 30 years of experience in discovery and development of new technology in the pharmaceutical and chemical industries; PhD. in chemical engineering from Purdue University.

  • View Online Source
    Yahoo - Infinity I/O Announces Appointment of Deborah... - [Cached Version]
    Published on: 3/1/2002    Last Visited: 3/1/2002  

    Dr. Terry Flanagan, founder and former CEO of JNI Corporation, and Dr. Suresh Mahajan, former Vice President of Research & Development at Catalytica, are also partners at Pulsar Ventures.

Wrong Person?

Related searches
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM14